Similar articles

• Clearance and biologic half-life as indices of intrinsic hepatic metabolism.

  Perrier D, Gibaldi M. Perrier D, et al. J Pharmacol Exp Ther. 1974 Oct;191(1):17-24. J Pharmacol Exp Ther. 1974. PMID: 4423599 No abstract available.
• [Pharmacokinetic models].

  Dahl S. Dahl S. Tidsskr Nor Laegeforen. 1973 Jan 30;93(3):157-62. Tidsskr Nor Laegeforen. 1973. PMID: 4693373 Norwegian. No abstract available.
• [A pharmacokinetic function for galenics].

  Dost FH. Dost FH. Arzneimittelforschung. 1971 May;21(5):712-7. Arzneimittelforschung. 1971. PMID: 5109699 German. No abstract available.
• Cutaneous pharmacokinetics: 10 steps to percutaneous absorption.

  Wester RC, Maibach HI. Wester RC, et al. Drug Metab Rev. 1983;14(2):169-205. doi: 10.3109/03602538308991388. Drug Metab Rev. 1983. PMID: 6341024 Review. No abstract available.
• [Dosage of drugs with regard to their distribution volume and biological half-life].

  Dahl SG. Dahl SG. Tidsskr Nor Laegeforen. 1974 Jun 30;94(18):1208-11. Tidsskr Nor Laegeforen. 1974. PMID: 4600750 Review. Norwegian. No abstract available.